X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Wall Street Cautiously Optimistic After Gene Therapy Deals

    RoboCap: A Robotic Capsule to Improve Gut Drug Delivery

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Wall Street Cautiously Optimistic After Gene Therapy Deals

    RoboCap: A Robotic Capsule to Improve Gut Drug Delivery

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Packaging & Logistic

New iQ™ platform from SCHOTT enhances safety, simplicity, and flexibility in pharma packaging

Content Team by Content Team
8th December 2017
in Packaging & Logistic
New iQ™ platform from SCHOTT enhances safety, simplicity, and flexibility in pharma packaging

International technology group SCHOTT is simplifying drug development and manufacturing with its new iQ™ platform. This holistic concept standardizes ready-to-use (RTU) syringes, vials, and cartridges within a single tub format to run on the same filling line, minimizing changeover time in between. The platform relies on the proven nest-and-tub format, which has been used by the pharmaceutical industry to fill syringes for decades. It is compatible with a diverse array of filling line models from different manufacturers. The platform was developed to help pharmaceutical companies retain flexibility in response to rapidly changing market conditions and demand, while ensuring patient safety with high quality ready-to-use containers.

New iQ™ platform from SCHOTT enhances safety, simplicity, and flexibility in pharma packaging
More concretely, the concept covers syriQ® prefillable syringes and adaptiQ® ready-to-use vials, as well as the new cartriQ™ ready-to-use cartridges, which are scheduled to be made available in 2018. A versatile portfolio of container formats and options is available for any pharmaceutical application.

Over the past several years, the number of blockbuster drugs in the development pipeline has decreased, while the number of biopharmaceuticals and other small-batch drugs has increased. This has put pressure on pharmaceutical and biotech companies to find flexible ways to fill small batches and/or different containers for different markets. iQ™ will help manufacturers quickly change from batch to batch or from vials to syringes or cartridges, and from drug to drug, as it is based on proven industry standards. SCHOTT is developing the iQ™ platform in collaboration with the world’s largest filling line suppliers to standardize packaging dimensions and simplify the entire filling process. In addition, SCHOTT works with the world’s largest elastomer component suppliers to ensure the offering of pre-validated and flexible container systems.

The iQ™ platform was designed to:

Maximize flexibility with a versatile portfolio of RTU containers and closure components to match a broad range of filling machines.

Reduce complexity by standardizing packaging, which speeds up installation and qualification times, reducing manufacturers’ time to market.

Enhance patient safety with the highest quality containers, packaged to eliminate cosmetic defects, container breakage, and particle contamination.

SCHOTT will launch this platform Oct. 24 – 26 at CPhI Worldwide’s InnoPack Event in Frankfurt, Germany, at booth H02 / hall 4.2.

Also at CPhI, Anil Busimi, SCHOTT Global Product Manager, will offer a presentation on iQ™ as part of the Pharma Insight Briefings series. His presentation “Future Pharma Manufacturing: RTU Packaging Solutions to Increase Flexibility and Increase Efficiency” will be held Oct. 24 from 3:10 p.m. to 3:40 p.m. in room G1A3.

SCHOTT is a leading international technology group in the areas of specialty glass and glass-ceramics. The company has more than 130 years of outstanding development, materials and technology expertise and offers a broad portfolio of high-quality products and intelligent solutions. SCHOTT is an innovative enabler for many industries, including the home appliance, pharma, electronics, optics, life sciences, automotive and aviation industries. SCHOTT strives to play an important part of everyone’s life and is committed to innovation and sustainable success. The group maintains a global presence with production sites and sales offices in 34 countries. With its workforce of approximately 15,000 employees, sales of 1.99 billion euros were generated in fiscal year 2015/2016. The parent company, SCHOTT AG, has its headquarters in Mainz (Germany) and is solely owned by the Carl Zeiss Foundation. As a foundation company, SCHOTT assumes special responsibility for its employees, society and the environment.

Previous Post

CSL Confirms Phase 3 Clinical Trial of New Therapy for Heart Attack Survivors

Next Post

Recipharm commences new supply contract and completes purchase of facility in Spain

Related Posts

News

Energy Crises May Impair European Medicine Supply Lines

2nd November 2022
News

Biopharma Sector Emergence of Third-Party Logistics Market

1st November 2022
EMA Advises Recall of AbbVie, Biogen MS Drug
Middle East and South Asia

With $6.26bn In Q1, The Indian Pharma Exports Grew By 8%

3rd August 2022
Airnov to exhibit range of healthcare packaging solutions to Indian market at Innopack Pharma Confex-South
Packaging & Logistic

Airnov to exhibit range of healthcare packaging solutions to Indian market at Innopack Pharma Confex-South

1st August 2022
DoKaSch Temperature Solutions and Japan Airlines sign Master Rental Agreement
Packaging & Logistic

DoKaSch Temperature Solutions and Japan Airlines sign Master Rental Agreement

13th July 2022
Vienna Airport and Lufthansa Cargo launch pharma cooperation
Packaging & Logistic

Vienna Airport and Lufthansa Cargo launch pharma cooperation

10th May 2022
Next Post
Recipharm commences new supply contract and completes purchase of facility in Spain

Recipharm commences new supply contract and completes purchase of facility in Spain

Latest News

Clinical Trials

Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

8th November 2022
Facilities & Operation

India Seeks Better Pharma Market Access In The UK: Official

8th November 2022
First Virtual Drug Study Tests 2 Likely Alzheimer Therapies
Clinical Trials

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

7th November 2022
Facilities & Operation

CPhI Pharma Index Shows Unprecedented Global Pharma Optimism

5th November 2022
$2 Million Gene Therapy Might Become The Standard In The US
Drug Development

$2 Million Gene Therapy Might Become The Standard In The US

5th November 2022
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In